Federal Register / Vol. 71, No.
191 / Tuesday, October 3, 2006 / Notices
Dated: September 26, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8451 Filed 10–2–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, ZEB1 OSR A J1 S
Training Grants Review.
Date: December 5, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Clarion Hotel Bethesda Park, 8400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: David George, PhD,
Director, Office of Scientific Review,
National Institute of Biomedical Imaging and
Bioengineering, 6707 Democracy Blvd., Suite
920, Bethesda, MD 20892, 301–496–8633,
georged1@mail.nih.gov.
Dated: September 27, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8444 Filed 10–2–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
rwilkins on PROD1PC63 with NOTICES
Musculoskeletal and Skin Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
VerDate Aug<31>2005 19:59 Oct 02, 2006 Jkt 211001
58419
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel, Innovative
Therapy Proposals.
Date: October 16–17, 2006.
Time: 7 p.m. to 8 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Eric H. Brown, PhD,
Scientific Review Administrator, National
Institute of Arthritis and Musculoskeletal and
Skin Diseases, National Institutes of Health,
6701 Democracy Blvd., Room 824, MSC
4872, Bethesda, MD 20892–4874. (301) 594–
4955. browneri@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel, Clinical
Trial Planning—R34.
Date: October 18, 2006.
Time: 11 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Kan Ma, PhD, Scientific
Review Administrator, NIH/NIAMS, EP
Review Branch, One Democracy Plaza, Suite
800, Bethesda, MD 20892–4872. 301–594–
4952. mak2@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel, Research
Scientist Development and Service Award.
Date: November 3, 2006.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Charles H. Washabaugh,
PhD, Scientific Review Administrator,
Review Branch, NIAMS/NIH, 6701
Democracy Blvd., Room 816, Bethesda, MD
20892. 301–451–4838.
washabac@mail.nih.gov.
PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\03OCN1.SGM
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel,
Corticosteroids in Childhood Disease.
Date: November 29, 2006.
Time: 9 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Michael L. Bloom, PhD,
Scientific Review Administrator, EP Review
Branch, NIH—NIAMS Institute, One
Democracy Plaza, Room 820, MSC 4872,
6701 Democracy Blvd, Bethesda, MD 20892–
487. 301–594–4953.
Michael_Bloom@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: September 27, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8445 Filed 10–2–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Cognitive
Behavioral Therapy for Irritable Bowel
Syndrome.
Date: October 16, 2006.
Time: 1 p.m. to 2 p.m.
03OCN1